PMID: 9437614Jan 23, 1998Paper

A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP)

Journal of Substance Abuse Treatment
Michael T FrenchA Thomas McLellan

Abstract

Drug abuse treatment programs need to know the cost of the services they provide. Indeed, continued public and private funding is now being linked to cost and performance measures, and programs can use financial data to improve organizational efficiency. However, one of the dangers of promoting cost studies at treatment programs is that most program staff are not technically prepared to perform a cost analysis and little user-friendly information is available to offer assistance. Furthermore, not all cost methods are consistent, which can lead to noncomparable estimates that are difficult to use for policy or planning purposes. Our paper tries to fill this gap in the research literature and provide treatment programs with a much-needed technical assistance tool. Specifically, we present a structured and scientifically-based instrument for estimating the economic cost of treatment services. The Drug Abuse Treatment Cost Analysis Program (DATCAP) is described in detail along with a companion instrument to analyze treatment financing; the Drug Abuse Treatment Financing Analysis Program (DATFin). The components of both instruments are outlined and findings from a variety of actual case studies are presented. Lastly, we discuss the ...Continue Reading

References

Mar 31, 1977·The New England Journal of Medicine·M C Weinstein, W B Stason
Jan 1, 1992·Journal of Substance Abuse Treatment·M T FrenchR L Hubbard
Mar 1, 1991·Alcoholism, Clinical and Experimental Research·H D Holder, J O Blose
Dec 1, 1990·The Journal of Applied Psychology·J NormandJ J Mahoney
Nov 24, 1989·JAMA : the Journal of the American Medical Association·J M Eisenberg
May 23, 1981·Lancet·K V LowsonJ M Bishop
Jun 2, 1983·The New England Journal of Medicine·M H BoyleS P Horwood
Oct 1, 1983·The Journal of Nervous and Mental Disease·A T McLellanK A Druley
Feb 1, 1995·The American Journal of Drug and Alcohol Abuse·M T French
Sep 1, 1994·Journal of Substance Abuse Treatment·C J BradleyJ V Rachal
Nov 1, 1995·Journal of Substance Abuse Treatment·G A ZarkinJ A Guyett

❮ Previous
Next ❯

Citations

Dec 21, 2000·Current Psychiatry Reports·P G Barnett
Dec 23, 2003·Drug and Alcohol Dependence·Jody L SindelarA Thomas McLellan
Jul 14, 2001·Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism·M T French
Jun 22, 2001·Drug and Alcohol Dependence·R Rosenheck, T Kosten
Jul 18, 2003·Journal of Substance Abuse Treatment·Pierre Kébreau AlexandreMaryann Barry
Sep 27, 2003·Journal of Substance Abuse Treatment·M Christopher RoebuckA Thomas McLellan
Dec 4, 2002·Addiction·Michael DennisUNKNOWN C. Y. T. Steering Committee
Nov 22, 2002·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Michael T FrenchRaymond L Stephens
Apr 9, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Steven D PinkertonRichard M Grimes
Mar 6, 2003·Journal of Marital and Family Therapy·Cynthia L Rowe, Howard A Liddle
Apr 29, 2011·Implementation Science : IS·Andrew R QuanbeckDennis McCarty
Nov 13, 2013·International Journal of Environmental Research and Public Health·Kevin N Griffith, Lawrence M Scheier
Jul 18, 2000·American Journal of Public Health·G S ZaricM L Brandeau
Dec 26, 2015·Evaluation and Program Planning·Sujha SubramanianFrances Babcock
Feb 7, 2009·Journal of Substance Abuse Treatment·K John McConnellDennis McCarty
Jul 15, 2015·Journal of Substance Abuse Treatment·Carolina BarbosaJeremy W Bray
Nov 3, 2010·Journal of Marital and Family Therapy·Triston B Morgan, D Russell Crane
Feb 27, 2003·Alcoholism, Clinical and Experimental Research·Michael E HiltonConstance Weisner
Nov 10, 2007·Health Economics·Anirban BasuHarold A Pollack
Jul 13, 2012·The American Journal of Drug and Alcohol Abuse·Gregory S ZaricJeff M Daiter
Nov 19, 2013·Journal of Substance Abuse Treatment·Robert P SchwartzJerome H Jaffe
Jan 4, 2013·Alcoholism Treatment Quarterly·Donald S ShepardBryan R Garner
Nov 14, 2008·Drug and Alcohol Dependence·Patrick M FlynnDonald S Shepard
May 22, 2007·Journal of Substance Abuse Treatment·Carey J A CarrRobert G Carlson
Jul 7, 2007·Journal of Substance Abuse Treatment·William S Cartwright
Feb 7, 2009·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Holly E FussellBentson H McFarland
Sep 27, 2005·Journal of Substance Abuse Treatment·Silvana K ZavalaHoward A Liddle
Jul 7, 2007·Journal of Substance Abuse Treatment·Todd W KnealingKenneth Silverman
Jun 20, 2012·Evaluation Review·Pierre K AlexandreBisma A Sayed
Jan 5, 2002·Medical Care Research and Review : MCRR·C H LemakT A D'Aunno
Dec 7, 2005·Medical Care Research and Review : MCRR·Rebecca WellsThomas A D'Aunno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism
Helena J Salomé, Michael T French
Journal of Substance Abuse Treatment
Michael T FrenchA Thomas McLellan
© 2021 Meta ULC. All rights reserved